BDBM536475 5-(1-(2-((5-chloro-2- ((2S,6S)-2,4,6- trimethylpiperazin-1- yl)pyridin-4-yl)amino)- 2-oxoethyl)-4-oxo- 4,6,7,8-tetrahydro-1H- dipyrrolo[1,2-a:2',3'-d] pyrimidin-3-yl)-3,4- difluoro-2-hydroxy- benzamide::US11242351, Compound I-54
SMILES C[C@H]1CN(C)C[C@H](C)N1c1cc(NC(=O)Cn2cc(-c3cc(C(N)=O)c(O)c(F)c3F)c3c2nc2CCCn2c3=O)c(Cl)cn1
InChI Key InChIKey=CRNDOQUVHYQTBI-UHFFFAOYSA-N
Data 1 Kd
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 536475
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 97.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair